Kris Jenner, the former top stock picker at T. Rowe Price Group, has raised more than $100 million for a hedge fund to invest in health-care and biotechnology stocks, Bloomberg reports, citing a person with knowledge of his plans.

Jenner will start the fund, dubbed Rock Springs Capital and based in Baltimore, later this year and is continuing to seek commitments from investors, according to the source. Jenner will run the fund with Mark Bussard and Graham McPhail, former T. Rowe Price analysts who left with Jenner in February. Jenner declined to comment on the fund.

Jenner had run T. Rowe Price’s $5.8 billion Health Sciences Fund (PRHSX) since 2000 and beat 83% of peers in the five years before he left, according to Bloomberg. The fund was T. Rowe Price’s best performer during that period, returning an annual average 13%.

Jenner earned a medical degree from Johns Hopkins University School of Medicine in Baltimore, then a Ph.D. in molecular biology from Oxford University in England. He reportedly joined T. Rowe in 1997 and took over the Health Sciences Fund in 2000.

T. Rowe appointed Taymour Tamaddon, formerly an analyst at the firm, to replace Jenner as manager of the Health Sciences Fund.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.